Treatment FailureHeart FailureTreatment OutcomeAntimalarialsDrug CombinationsSulfadoxinePyrimethamineDrug ResistanceRetrospective StudiesDrug Therapy, CombinationMalaria, FalciparumAnti-Bacterial AgentsChloroquineRecurrenceFollow-Up StudiesProblem SolvingProspective StudiesTime FactorsArtemisininsAmodiaquineKidney Failure, ChronicFluorenesProguanilFailure to ThrivePlasmodium falciparumAtovaquoneSurvival AnalysisDihydropteroate SynthasePrognosisHIV InfectionsRisk FactorsDrug Resistance, ViralCefiximeAnti-HIV AgentsDrug Administration ScheduleAntiprotozoal AgentsLiver Failure, AcuteAntitubercular AgentsMicrobial Sensitivity TestsCohort StudiesParasitic Sensitivity TestsPenicillin G ProcaineAmoxicillinAntineoplastic Combined Chemotherapy ProtocolsSurvival RateDrug Resistance, BacterialMetronidazoleGonorrheaDisease-Free SurvivalLiver FailureDrug MonitoringSocial ProblemsCombined Modality TherapyPredictive Value of TestsAzithromycinViral LoadMelarsoprolFluoxymesteroneEthanolaminesKaplan-Meier EstimateParasitemiaMultiple Organ FailureGenotypeSeverity of Illness IndexEquipment FailureAntiretroviral Therapy, Highly ActiveUgandaAcute DiseaseSalvage TherapyChronic DiseaseHodgkin DiseaseDouble-Blind MethodAnti-Infective AgentsMutationDoxorubicinTrypanosoma brucei gambienseCeftriaxonePatient ComplianceTetrahydrofolate DehydrogenaseDisease ProgressionVincristineMycoplasma genitaliumAntimonyCD4 Lymphocyte CountPharyngeal DiseasesPolymerase Chain ReactionCardiac Output, LowClinical Trials as TopicAlgorithmsPrednisoneAcute Kidney InjuryNeisseria gonorrhoeaeStaphylococcal InfectionsDrug Resistance, NeoplasmAntineoplastic AgentsHIV-1PrevalenceHeart Failure, SystolicAnti-Retroviral AgentsVancomycin